Therapeutic potential of splice-switching oligonucleotides.

Oligonucleotides
John A BaumanRyszard Kole

Abstract

Alternative splicing enables a single pre-messenger RNA transcript to yield multiple protein isoforms, making it a major contributor to the diversity of the proteome. While this process is essential for normal development, aberrations in alternative splicing are the cause of a multitude of human diseases. Methods for manipulating alternative splicing would thus be of therapeutic value. Chemically modified antisense oligonucleotides that alter alternative splicing by directing splice site selection have been developed to achieve this end. These splice-switching oligonucleotides (SSOs) have been applied to correct aberrant splicing, induce expression of a therapeutic splice variant, or induce expression of a novel therapeutic splice variant in a number of disease-relevant genes. Recently, in vivo efficacy of SSOs has been reported using animal disease models, as well as in results from the first clinical trial.

References

Oct 1, 1990·Journal of the Neurological Sciences·E P HoffmanT A Partridge
Dec 1, 1989·Journal of the Neurological Sciences·L V NicholsonJ B Harris
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Z Dominski, R Kole
Aug 1, 1996·Nucleic Acids Research·C N TennysonR G Worton
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·H SierakowskaR Kole
Apr 29, 1998·American Journal of Human Genetics·S GiladA Bar-Shira
May 20, 1999·American Journal of Human Genetics·S N TeraokaP Concannon
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·J K DohertyG M Clinton
Dec 30, 1999·Genome Research·A A MironovM S Gelfand
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·G LacerraR Kole
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·C J MannS D Wilton
Jan 11, 2000·Nucleic Acids Research·P Rodriguez-Tomé, P Lijnzaad
Jul 27, 2001·Human Molecular Genetics·J C van DeutekomG J van Ommen
Feb 13, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Matthew D MailmanThomas W Prior
Apr 17, 2002·The Journal of Biological Chemistry·Hiroshi MiyajimaKazunori Imaizumi
Apr 23, 2002·Nature Reviews. Genetics·Luca CartegniAdrian R Krainer
Oct 17, 2002·The Journal of Biological Chemistry·Danielle R MercatanteRyszard Kole
Nov 12, 2002·Nature Biotechnology·Peter SazaniRyszard Kole
Dec 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Thipparat SuwanmaneeRyszard Kole
Dec 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Benjamin P LewisSteven E Brenner
Jan 14, 2003·Nature Structural Biology·Luca Cartegni, Adrian R Krainer
Feb 26, 2003·Genes & Development·Nuno André Faustino, Thomas A Cooper
Mar 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Leigh A SkordisFrancesco Muntoni
Apr 2, 2003·Human Molecular Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Jul 2, 2003·Nature Genetics·Tsuyoshi Kashima, James L Manley
Jul 23, 2003·Human Molecular Genetics·Bianca L GebskiStephen D Wilton
Dec 19, 2003·American Journal of Human Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Feb 10, 2004·Biochemical and Biophysical Research Communications·Natalia N SinghRavindra N Singh
Apr 24, 2004·Oligonucleotides·Ryszard KoleTiffany Williams
May 21, 2004·The New England Journal of Medicine·Nancy J Olsen, C Michael Stein

❮ Previous
Next ❯

Citations

Apr 10, 2012·Molecular Pharmaceutics·Christopher J Cheng, W Mark Saltzman
May 16, 2013·Molecular Therapy. Nucleic Acids·Rafal GoraczniakSamuel I Gunderson
Aug 29, 2013·Molecular Therapy. Nucleic Acids·Kim A LennoxMark A Behlke
Feb 6, 2010·Médecine sciences : M/S·Dominique Labie, Jean-Claude Kaplan
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Francesca ZammarchiLuca Cartegni
Dec 16, 2010·The Journal of Biological Chemistry·Marilyn K ParraJohn G Conboy
Oct 10, 2009·Cardiovascular Research·Natee JearawiriyapaisarnMonte S Willis
Apr 22, 2010·Human Molecular Genetics·Susan A M MuldersDerick G Wansink
Aug 20, 2010·Nucleic Acids Research·John A BaumanRyszard Kole
Sep 29, 2011·Nucleic Acids Research·Jing LiuDavid R Corey
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·C Frank Bennett, Eric E Swayze
Jan 5, 2013·International Journal of Biological Sciences·Aleksandra ShchelkunovaAlexander V Kazansky
Feb 11, 2014·Nucleic Acid Therapeutics·Burcu BestasSamir El Andaloussi
Jul 26, 2013·Therapeutic Delivery·Johannes Winkler
Dec 26, 2013·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Tan ZhangOsvaldo Delbono
Aug 29, 2013·Chemical Communications : Chem Comm·Alice GhidiniRoger Strömberg
Apr 17, 2012·Nature Chemical Biology·Frank RigoC Frank Bennett
Mar 10, 2015·Advanced Drug Delivery Reviews·Prisca BoisguérinBernard Lebleu
Apr 1, 2014·Immunologic Research·Linda Yip, C Garrison Fathman
Mar 15, 2016·Antioxidants & Redox Signaling·Iraida G Sharina, Emil Martin
Nov 7, 2012·Chembiochem : a European Journal of Chemical Biology·Fanny MarlinCarine Giovannangeli
Jan 25, 2011·Journal of Neuroscience Research·Jonathan J Magaña, Bulmaro Cisneros
Nov 10, 2011·The Journal of Pathology·Jonathan K Watts, David R Corey
Nov 19, 2015·International Journal of Molecular Sciences·Zodwa DlaminiRodney Hull
Apr 4, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seyed Mohammad Ali Hosseini RadEhsan Arefian
Mar 10, 2015·Peptides·Martínez-Montiel NancyMartínez-Contreras Rebeca
Jun 4, 2011·Bioengineered Bugs·John A Bauman, Ryszard Kole
Dec 5, 2013·Artificial DNA, PNA & XNA·Venubabu KotikamVaijayanti A Kumar
Jan 30, 2013·Biochimica Et Biophysica Acta·Piret ArukuuskUlo Langel
Feb 11, 2015·Chemical Communications : Chem Comm·Stefan MiltonRoger Strömberg
Sep 25, 2014·Advanced Drug Delivery Reviews·Deepak ChitkaraRam I Mahato
Aug 16, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Matt GoodingCaitriona M O'Driscoll
Sep 23, 2016·Nucleic Acid Therapeutics·Jana KralovicovaIgor Vorechovsky
Jan 30, 2010·International Journal of Toxicology·Peter SazaniStephen B Shrewsbury
Oct 6, 2017·Genes·Nancy Martínez-MontielRebeca D Martínez-Contreras

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
transgenic
biopsy
biopsies
SMA
ISS

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Saovaros SvastiRyszard Kole
© 2021 Meta ULC. All rights reserved